Drug Shortage Report for TEVA-MYCOPHENOLATE

Last updated on 2019-12-06 History
Report ID 99947
Drug Identification Number 02364883
Brand name TEVA-MYCOPHENOLATE
Common or Proper name TEVA-MYCOPHENOLATE 250MG CAPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) MYCOPHENOLATE MOFETIL
Strength(s) 250MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code L04AA
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-28
Estimated end date 2020-01-31
Actual end date 2019-12-05
Shortage status Resolved
Updated date 2019-12-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-12-06 English Compare
v5 2019-12-05 French Compare
v4 2019-12-05 English Compare
v3 2019-11-29 English Compare
v2 2019-11-28 French Compare
v1 2019-11-28 English Compare

Showing 1 to 6 of 6